Overview

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of valsartan and amlodipine in fixed dose combination in adults with moderate, inadequately controlled hypertension. There was an optional study extension for eligible patients who wanted to participate that contains the triple therapy (ie, hydrochlorothiazide+ amlodipine/valsartan).
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Amlodipine, Valsartan Drug Combination
Angiotensin Receptor Antagonists
Hydrochlorothiazide
Olmesartan
Olmesartan Medoxomil
Valsartan